NIH-funded research R01 grant

Help with health insurance for young adult cancer survivors

Official title: A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance among Young Adult Cancer Survivors

Funded at Utah State Higher Education System--University of Utah · NIH-11332490 · Data updated 2026-11-12

A program helps young adult cancer survivors understand their health insurance, reduce medical costs, and stay on track with recommended follow-up care.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startJune 14, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$646,275
NIH project number5R01CA276825-04
Project IDNIH-11332490 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are YA cancer survivors aged 26–39 who have completed treatment and have health insurance or are navigating coverage.

Less likely to help

Those without any ongoing healthcare needs or who are not navigating insurance may see limited benefit.

What this research studies

This project tests a 4-session virtual navigation program designed for young adults (ages 26 to 39) who have completed cancer treatment. It aims to improve insurance literacy, reduce financial toxicity, and increase adherence to survivorship care guidelines. The study uses a randomized controlled design to compare CHAT-S against usual care, measuring changes in insurance understanding, costs faced, and care uptake. If successful, it could make it easier for survivors to access needed follow-up services without overwhelming costs.

Why it matters

Potential benefit: If successful, survivors may experience clearer insurance coverage, lower out-of-pocket costs, and better access to recommended follow-up care.

How similar studies have gone: Previous pilot work showed the approach was feasible, acceptable, and suggested early signs of benefit; this trial will provide more definitive results.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Kirchhoff, Anne C — Utah State Higher Education System--University of Utah
  • Study coordinator: Kirchhoff, Anne C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.